Given the prominent role of Wnt signaling in RA, we hypothesised that sclerostin blockade may exert a bone-protective or restoring action, both locally and systemically, without affecting progression of inflammation (consistent with our previous study). Here, SOST is linked to rheumatoid arthritis.